Medicine for treating hysteromyoma and preparation method thereof

A technology for uterine fibroids and drugs, applied in the field of medicine, can solve the problems of liver damage, less use, and affecting the secretion of estrogen and progesterone.

Inactive Publication Date: 2018-11-27
浙江因诺泰医疗器械有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Looking at the treatment methods, surgical treatment has the following problems: the recurrence rate after myomectomy is as high as 15%-41%, and more than half of the patients need reoperation; The supply is blocked, which will lead to premature ovarian failure; subtotal hysterectomy will cause cervical cancer in 1%-2% of the preserved cervix, and this "stump cancer" will have unexpected effects on surgical treatment and reflexology Difficulties; Intrafascial hysterectomy and central resection of the uterine body are difficult to operate and require high technical skills for doctors
[0004] (1) Androgen, itself a sex hormone, is the earliest clinically used drug for the treatment of uterine fibroids. It has certain effects, but often has relatively large side effects, which limits its application;
[0005] (2) Gonadotropin-releasing hormone agonists, such drugs can significantly reduce the size of fibroids and reduce uterine bleeding. The main side effect of this drug is menopause-like changes related to low estrogen, and long-term use can cause osteoporosis;
At the same ti

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating hysteromyoma and preparation method thereof
  • Medicine for treating hysteromyoma and preparation method thereof
  • Medicine for treating hysteromyoma and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0020] A medicine for treating uterine fibroids and a preparation method thereof, comprising 0.35% sodium carboxymethylcellulose, 0.8% cystamine, 1% EDC, and 1% N-hydroxysuccinyl Amine (NHS), 0.1% sodium hyaluronate dissolved in pure water at 80°C (the remaining weight is pure water), reacted at 80°C for 8 hours, and the solution obtained after the reaction was dialyzed through a 1000D dialysis bag at 40°C for 24 Hours, after completion, freeze-dried into powder. When in use, 1 g of the prepared freeze-dried powder is dissolved in 98 g of pure water, stirred to form a gel, and 1 g of glycyrrhetinic acid is added, dispersed evenly, and used in the form of smearing on the patient's vagina.

[0021] The medicine obtained by the technical scheme obtains its beneficial effect and performance through the following experimental analysis.

[0022] Antagonistic effect of glycyrrhetinic acid on estradiol in vitro

[0023] 1.1 Instruments and equipment

[0024] 0.22um filter, electric...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine for treating hysteromyoma and a preparation method thereof. The medicine is characterized in that the effective component of the medicine composition is glycyrrhetinic acid. The invention relates to the medicine for treating hysteromyoma and the preparation method thereof. It is creatively found that glycyrrhetinic acid can effectively inhibit hysteromyoma, and specifically, treatment is achieved through the anti-estrogenic function of glycyrrhetinic acid. Other normal tissue and cells are protected to the largest extent while hysteromyoma is inhibited, and side effects of glycyrrhetinic acid are small.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a medicine for treating uterine fibroids and a preparation method thereof. Background technique [0002] Uterine fibroids, also known as uterine fibroids, are composed of smooth muscle fibers and a small amount of fibrous connective tissue. The former is a special tumor component, and the latter is a supporting tissue, so its exact name is uterine leiomyoma, which is referred to clinically as "uterine fibroids". According to a large number of clinical observations and experimental results, it is found that uterine fibroids are hormone-dependent tumors, and estrogen is the main factor that promotes the growth of fibroids. The clinical manifestations of uterine fibroids vary depending on the location, size, speed, degeneration and complications of fibroids. The most common symptom is uterine bleeding, accounting for more than 1 / 3, manifested as heavy menstruation, prolonged mens...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/06A61K31/56A61P35/00
CPCA61K9/0034A61K9/06A61K31/56A61K47/36A61P35/00
Inventor 陈跃义杨维童振飞罗海浪张可研徐丽君
Owner 浙江因诺泰医疗器械有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products